日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome

异常的SUMO化限制了可靶向的癌症免疫肽组。

Demel, Uta M; Meurer, Anna; Zaghla, Badeel Kh Q; Atay, Bilge; Steiert, Daniel; Hummel, Luca V; Isaakidis, Konstandina; Zang, Chuanbing; Korenkov, Michael; Schielin, Marlon; Yousefian, Schayan; Mecklenbräuker, Shima; Kirchner, Marieluise; Haas, Simon; Busse, Antonia; Mertins, Philipp; Müller, Stefan; Wirth, Matthias; Klatt, Martin G; Keller, Ulrich

Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)

接受特殊姑息治疗的晚期癌症患者的心力衰竭治疗(EMPATICC 试验)

Anker, Markus S; Mahabadi, Amir A; Totzeck, Matthias; Tewes, Mitra; Khan, Muhammad Shahzeb; Mincu, Raluca I; Hendgen-Cotta, Ulrike B; Michel, Lars; Mathew, Baicy; Drescher, Ophelia; Schuler, Martin; Keller, Ulrich; Rieger, Kathrin; Ahn, Johann; Bullinger, Lars; Modest, Dominik P; Denecke, Corinna; Kretzler, Lucie; Ramer, Luisa V; Krug, Danara; Landmesser, Ulf; Lehmann, Lorenz H; Frey, Norbert; Bercker, Sven; Laufs, Ulrich; Böhm, Michael; Mahfoud, Felix; Merkely, Bela; Diek, Monika; Butler, Javed; Veiser, Anja; Heise, Tim; Hellmich, Martin; Placzek, Marius; Friede, Tim; Anker, Stefan D; Rassaf, Tienush

Ultra-high-scale cytometry-based cellular interaction mapping

基于超大规模细胞计数法的细胞相互作用图谱

Vonficht, Dominik; Jopp-Saile, Lea; Yousefian, Schayan; Flore, Viktoria; Simó Vesperinas, Inés; Teuber, Ruth; Avanesyan, Bogdan; Luo, Yanjiang; Röthemeier, Caroline; Grünschläger, Florian; Fernandez-Vaquero, Mirian; Fregona, Vincent; Ordoñez-Rueda, Diana; Schmalbrock, Laura K; Deininger, Luca; Yamachui Sitcheu, Angelo Jovin; Gu, Zuguang; Funk, Maja C; Mikut, Ralf; Heikenwälder, Mathias; Eggert, Angelika; von Stackelberg, Arend; Kobold, Sebastian; Krönke, Jan; Keller, Ulrich; Trumpp, Andreas; Hegazy, Ahmed N; Eckert, Cornelia; Hübschmann, Daniel; Haas, Simon

InstaNovo enables diffusion-powered de novo peptide sequencing in large-scale proteomics experiments.

InstaNovo 可在大规模蛋白质组学实验中实现扩散驱动的从头肽测序。

Eloff Kevin, Kalogeropoulos Konstantinos, Mabona Amandla, Morell Oliver, Catzel Rachel, Rivera-de-Torre Esperanza, Jespersen Jakob Berg, Williams Wesley, van Beljouw Sam P B, Skwark Marcin J, Laustsen Andreas Hougaard, Brouns Stan J J, Ljungars Anne, Schoof Erwin M, Van Goey Jeroen, Keller Ulrich Auf dem, Beguir Karim, Carranza Nicolas Lopez, Jenkins Timothy P

A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer

晚期唾液腺癌中以巨噬细胞为主的免疫抑制微环境及其治疗弱点

Zuljan, Erika; von der Emde, Benjamin; Piwonski, Iris; Pestana, Ana; Klinghammer, Konrad; Mock, Andreas; Horak, Peter; Heining, Christoph; Klauschen, Frederick; Pretzell, Ina; Boerries, Melanie; Brandts, Christian H; Kreutzfeldt, Simon; Teleanu, Maria-Veronica; Hübschmann, Daniel; Morris, Luc G T; Heiland, Max; Keller, Ulrich; Conrad, Thomas; Glimm, Hanno; Fröhling, Stefan; Ochsenreither, Sebastian; Keilholz, Ulrich; Blanc, Eric; Beule, Dieter; Rieke, Damian T

Growth Differentiation Factor-15: A Promising Biomarker and Target in Cancer Patients

生长分化因子-15:癌症患者中一种有前景的生物标志物和治疗靶点

Anker, Markus S; Bullinger, Lars; Keller, Ulrich; Khan, Muhammad Shahzeb

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

德国淋巴瘤联盟开展的一项II期研究结果显示,伊布替尼联合奥妥珠单抗治疗未经化疗的晚期滤泡性淋巴瘤疗效显著。

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

A phase I study of MAGE-A1-targeted T1367 T-cell receptorbased cell therapy in patients with advanced multiple myeloma

一项针对晚期多发性骨髓瘤患者的MAGE-A1靶向T1367 T细胞受体细胞疗法的I期研究

Krüger, Josefine; Obenaus, Matthias; Blau, Igor Wolfgang; Hoser, Dana; Vaegler, Martin; Rauschenbach, Hana; Anagnostopoulos, Ioannis; Jöhrens, Korinna; Scheuplein, Vivian; Kieback, Elisa; Böhme, Judith; Von Brünneck, Ann-Christin; Krönke, Jan; Busse, Antonia; Willimsky, Gerald; Blankenstein, Thomas; Pezzutto, Antonio; Keller, Ulrich; Nogai, Axel

Erratum to: "Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance"

更正:“伊布替尼和奥妥珠单抗联合治疗未经治疗的晚期滤泡性淋巴瘤:德国淋巴瘤联盟 II 期研究的结果”

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study

一项多中心真实世界研究评估了 glofitamab 治疗复发/难治性大 B 细胞淋巴瘤的安全性和有效性

Shumilov, Evgenii; Wurm-Kuczera, Rebecca; Kerkhoff, Andrea; Wang, Meng; Melchardt, Thomas; Holtick, Udo; Bacher, Ulrike; Staber, Philipp; Mazzeo, Paolo; Leng, Corinna; Böckle, David; Hölscher, Alexander; Kauer, Joseph; Rotter, Natalia; Vucinic, Vladan; Rudzki, Jakob; Nachbaur, David; Bücklein, Veit; Schnetzke, Ulf; Krämer, Isabelle; Wille, Kai; Hasse, Alexander; von Tresckow, Bastian; Hänel, Mathias; Koenecke, Christian; Velazquez, Giuliano Filippini; Viardot, Andreas; Schmid, Christoph; Thurner, Lorenz; Wolf, Dominik; Subklewe, Marion; Dreyling, Martin; Dreger, Peter; Dietrich, Sascha; Keller, Ulrich; Jäger, Ulrich; Greil, Richard; Pabst, Thomas; Lenz, Georg; Chapuy, Björn